These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 501087)

  • 21. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
    Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
    J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biosynthesis and post-synthetic modification of a precursor (pro-C5) of the fifth component of mouse complement (C5).
    Ooi YM; Colten HR
    J Immunol; 1979 Dec; 123(6):2494-8. PubMed ID: 501083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid isolation and characterization of native mouse complement components C3 and C5.
    Van den Berg CW; Van Dijk H; Capel PJ
    J Immunol Methods; 1989 Aug; 122(1):73-8. PubMed ID: 2760478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular cloning of rat C4b binding protein alpha- and beta-chains: structural and functional relationships among human, bovine, rabbit, mouse, and rat proteins.
    Hillarp A; Wiklund H; Thern A; Dahlbäck B
    J Immunol; 1997 Feb; 158(3):1315-23. PubMed ID: 9013975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural C3 diversity in fish: characterization of five forms of C3 in the diploid fish Sparus aurata.
    Sunyer JO; Tort L; Lambris JD
    J Immunol; 1997 Mar; 158(6):2813-21. PubMed ID: 9058817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The complement system in rainbow trout (Salmo gairdneri). II. Purification and characterization of the fifth component (C5).
    Nonaka M; Natsuume-Sakai S; Takahashi M
    J Immunol; 1981 Apr; 126(4):1495-8. PubMed ID: 7204972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal, antigen-specific, T cell contrasuppressor factor expresses determinants of TCR alpha-chain (not necessarily TCR beta-chain), having a molecular mass of about 40 kDa.
    Paliwal V; Friedman AM; Ptak W; Askenase PW
    J Immunol; 1994 Mar; 152(6):2811-20. PubMed ID: 7511628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
    Perez HD; Chenoweth DE; Goldstein IM
    J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The terminal membrane C5b-9 complex of human complement. Evidence for the existence of multiple protease-resistant polypeptides that form the trans-membrane complement channel.
    Bhakdi S; Tranum-Jensen J; Klump O
    J Immunol; 1980 May; 124(5):2451-7. PubMed ID: 6154104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
    Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
    Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification of the third and fifth components of human complement: application of hydrophobic chromatography.
    Kunkel SL; Kreutzer DL; Goralnick S; Ward PA
    J Immunol Methods; 1980; 35(3-4):337-51. PubMed ID: 7400588
    [No Abstract]   [Full Text] [Related]  

  • 33. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Components of human complement system. Testing and isolation of C3 and C5].
    Kosiak AV; Shukun SA; Poddubkova TN; Chikh VP; Surovtsev VI
    Biokhimiia; 1990 Feb; 55(2):276-84. PubMed ID: 2340315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoadsorbent affinity purification of the fifth component (C5) of human complement and development of a highly sensitive hemolytic assay.
    Wetsel RA; Jones MA; Kolb WP
    J Immunol Methods; 1980; 35(3-4):319-35. PubMed ID: 6995534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of a hydrophobic domain in human C5.
    Al Salihi A; Ripoche J; Fontaine M
    Mol Immunol; 1988 Apr; 25(4):367-77. PubMed ID: 3398860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The fifth component of complement (C5): purification without activation.
    Dessauer A; Rother U
    Immunobiology; 1983 May; 164(5):370-9. PubMed ID: 6347874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fifth component of human complement: purification from plasma and polypeptide chain structure.
    Tack BF; Morris SC; Prahl JW
    Biochemistry; 1979 Apr; 18(8):1490-7. PubMed ID: 106884
    [No Abstract]   [Full Text] [Related]  

  • 39. Quantitation and stability of the fifth component of complement (C5) in bronchoalveolar lavage fluids obtained from non-human primates.
    Kolb WP; Kolb LM; Wetsel RA; Rogers WR; Shaw JO
    Am Rev Respir Dis; 1981 Feb; 123(2):226-31. PubMed ID: 7235362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A unique complement derived chemotactic factor for tumor cells.
    Romualdez AG; Ward PA
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4128-32. PubMed ID: 172896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.